Associated Papers
The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.
Lucas LM et al.
Pharmacological Reviews, 2022
Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer.
Elster N et al.
Therapeutic Advances in Medical Oncology, 2018
ERBB4 promoter polymorphism is associated with poor distant disease-free survival in high-risk early breast cancer.
Kurppa KJ et al.
Plos One, 2014
Somatic mutations of the ERBB4 kinase domain in human cancers.
Soung YH et al.
International Journal of Cancer, 2006
Select a paper to view details